3 Warning Signs That Micron Investors Shouldn't Ignore

Micron's stock has risen more than 500% over the past year, but the article argues its valuation already assumes sustained AI-memory demand and near-perfect execution. The company reported fiscal Q3 revenue of $41.46 billion and gross margin above 84%, while guiding for roughly $50 billion of Q4 revenue and a 86% gross margin; HBM supply is reportedly sold out through 2027. Key risks are tens of billions of dollars of AI-capacity investment, intensifying competition from Samsung and SK Hynix, and a potential strike at Micron's Taiwan plants that could disrupt production and customer deliveries.

Analysis

MU’s key equity risk is no longer demand visibility but operating leverage at the peak of a memory cycle. HBM allocation agreements protect near-term utilization, yet they can obscure the more important variable for FY27-FY28: whether incremental capacity clears at premium pricing once Samsung and SK Hynix qualify competing HBM generations across more accelerator platforms. A modest HBM pricing reset would have an outsized effect on MU’s earnings multiple because the market is underwriting both volume growth and sustained mix-driven margins.

The Taiwan labor issue matters less as a standalone production loss than as evidence that peak-cycle rents are being contested. A permanent profit-sharing structure would raise the marginal cost base at precisely the point MU is adding fixed-cost capacity; if replicated across sites, it lowers through-cycle free-cash-flow conversion and weakens the argument for a structurally higher valuation versus prior memory cycles. Any disruption also gives NVDA and hyperscaler customers an incentive to accelerate dual-sourcing qualifications, increasing SK Hynix’s and Samsung’s strategic leverage.

Over the next 1-3 months, the relevant catalyst is not another strong reported quarter but evidence of HBM4 qualification timing, customer concentration, and whether capex rises faster than operating cash flow. Over 6-18 months, watch conventional DRAM/NAND supply additions: AI-driven HBM capacity can tighten commodity DRAM temporarily, but a broad capacity response creates the familiar risk of oversupply after 2027. Consensus appears too focused on sold-out language and insufficiently focused on the return profile of the capacity being built.

The contrarian bullish case is that HBM remains supply-constrained longer than expected because yield and packaging bottlenecks, rather than wafer capacity, are binding. That would support MU’s pricing power and make a labor settlement immaterial; the thesis is falsified if competitor qualifications slip while MU maintains premium pricing and raises long-term gross-margin targets.

Key Decisions for Investors

• Reduce/avoid adding to outright MU into the next earnings print; use a 1-3 month tactical short only after confirmation of weaker HBM pricing, a capex increase without higher FCF guidance, or a formal Taiwan strike notice. Cover if management raises FY27 HBM margin or supply-allocation commentary.
• Express relative value through long SKHY / short MU over 6-12 months, sized beta-neutral. SK Hynix has greater leverage to incumbent HBM leadership and could gain from customer dual-sourcing; exit if MU demonstrates material HBM4 share gains or SK Hynix reports yield/qualification delays.
• For existing MU longs, buy 3-6 month downside put spreads around earnings rather than sell the position outright. The asymmetry is unfavorable when expectations are elevated: strong results may be largely discounted, while any guide-down in margin, utilization, or capex returns can drive multiple compression.
• Set an alert for Taiwan labor escalation and for customer concentration disclosure. A strike vote alone is not sufficient to trade; initiate downside exposure only if production schedules, shipment timing, or customer qualification activity are explicitly affected.